Financhill
Back

Phreesia 10K Form

Sell
32

PHR
Phreesia

Last Price:
21.03
Seasonality Move:
11.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive PHR News And Ratings

See the #1 stock for the next 7 days that we like better than PHR

PHR Financial Statistics

Sales & Book Value

Annual Sales: $356.3M
Cash Flow: $-10.94M
Price / Cash Flow: 0
Annual Sales: $4.46
Price / Book: 4.71

Profitability

EPS (TTM): -2.51000
Net Income (TTM): $-136.89M
Gross Margin: $232.29M
Return on Equity: -52.07%
Return on Assets: -37.83%

Phreesia Earnings Forecast

Key Phreesia Financial Ratios

  • The Gross Profit Margin over the past 7 years for PHR is 65.19%.
  • The Selling, General & Administrative Expenses for PHR have been equal to 63.69% of Gross Profit Margin.
  • The Research & Development expenses have been 31.53% of Revenue.
  • The Interest Expense is -1.35% of Operating Income.
  • The Net Earning history of PHR is -38.42% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Phreesia Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Technology
Sector: Health Care
Current Symbol: PHR
CUSIP: 71944F
Website: phreesia.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 1.78
Quick Ratio: 1.38

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 122.28

PHR Technical Analysis vs Fundamental Analysis

Sell
32
Phreesia (PHR) is a Sell

Is Phreesia a Buy or a Sell?

  • Phreesia stock is rated a Sell
    The current Phreesia [PHR] share price is $21.01. The Score for PHR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.